Anpharm Przedsiębiorstwo Farmaceutyczne S.A.

Manufacture of pharmaceutical preparations

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2001-07-09
Share capital
7,892,148.00 PLN
Activity description

Anpharm Przedsiębiorstwo Farmaceutyczne is a manufacturing facility of the Servier Group in Poland that produces pharmaceuticals. It adheres to GMP quality standards and exports its products to 30 countries, focusing on therapeutic areas such as cardiometabolism, oncology, and neurology.

Registered address
Annopol 6B, 03-236 Warszawa, Poland
Website
Opening hours
Mon–Fri, 7:00–16:00
Email
Phone
Social media
Electronic delivery address
AE:PL-73816-73944-AWEHT-26

Financials

Revenue history (in m)

Filing timeliness

Financial statements were filed on time, on average 33 days early. All were audited by a statutory auditor.

  • 202525/02/2026
  • 202414/04/2025
  • 202310/04/2024
  • 202213/04/2023
  • 202113/04/2022
  • 202026/02/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.

Sector · Manufacturing471 / 24,649
Top 1.9%
City · Warszawa387 / 56,955
Top <1%
Voivodeship · Mazowieckie492 / 77,195
Top <1%
Country · Poland1,373 / 298,026
Top <1%

Results vs industry

Revenue
This companyUSD 160.17mMedianUSD 917.74kAverageUSD 25.93m
Net profit
This companyUSD 6.71mMedianUSD 14.44kAverageUSD 2.78m
Operating costs
This companyUSD 149.95mMedianUSD 860.03kAverageUSD 21.46m
Assets
This companyUSD 105.99mMedianUSD 911.84kAverageUSD 31.78m

Offer

Certifications: GMP

Websites

  • anpharm.plStrona główna – Servier Anpharm Polska
    WordPress 6.7Yoast SEOApache

Trademarks

The company currently holds no active trademarks with the Polish Patent Office. 11 marks have expired or were not registered. The first mark was filed in 1995.

MarkNumberClassesStatusProtected until
glimebet (word)Z.2828495Expired –
ANPHARM Z.2748545Expired –
CORAMIL (word)Z.2614345Expired –
RAMIVAC (word)Z.2614325Expired –
URIBICALAN (word)Z.2576205Not registered –
MarkProtected until
glimebet (word)–
ANPHARM –
CORAMIL (word)–
RAMIVAC (word)–
URIBICALAN (word)–

Job offers

The company has its own careers page: anpharm.pl/dolacz-do-nas.

Authorized Representatives

Marcin Wiesław Andziak age 49 – Attorney-in-fact (joint)
Jérôme Charles Schneeberger age 50 – Management Board Member
Philippe Dartiguelongue age 62 – Management Board Member
Grzegorz Trębiński age 48 – Attorney-in-fact (joint)

Manner of representation

Each member of the management board has the right to represent the company independently.

Supervisory board

Gilles Belloir – Supervisory Board Member
Hani Friedman – Supervisory Board Member
Stephane Mascarau – Supervisory Board Member

Beneficial owners

Person

Sanctions and PEP

Sanctions

No matches (EU, UN, US, UK, MSWiA, World Bank)

PEP

No matches

Bank accounts

Registered as a VAT taxpayer on 1995-12-01.

Debt

No entries in the National Debtors Register (KRZ).

Public aid

No public aid cases recorded in the last 10 years.

Regulatory authorisations

AuthorityTypeStatus
BDO register entry Active

Competitors

Name
Adamed Pharma S.A.
Biofarm sp. z o.o.
Delpharm Poznań S.A.
Tarchomińskie Zakłady Farmaceutyczne Polfa S.A.
Przedsiębiorstwo Farmaceutyczne Lek-Am sp. z o.o.
Natur Produkt Pharma sp. z o.o.
Sandoz Polska sp. z o.o.
ICN Polfa Rzeszów S.A.
Synoptis Pharma sp. z o.o.
Wörwag Pharma Operations sp. z o.o.

Change history

DateEvent
2008-04-14Share capital reduction
2002-03-18Share capital increase
2001-07-09Entered in the register

FAQ

Last updated: 2026-04-01